3.2.1.123	0.3	-	ganglioside Gb3Cer	isoform EHCase II, pH 5.5 and 37°C	732295	
3.2.1.123	0.35	-	beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide	pH 6.0, 37°C	751102	
3.2.1.123	6.6	-	C6-7-nitro-2,1,3-benzoxadiazole-glucosylceramide	isoform EGCrP1, at pH 6.0 and 37°C	732178	
3.2.1.123	13	-	ganglioside GM1a	isoform EHCase II, pH 5.5 and 37°C	732295	
3.2.1.123	13.8	-	C6-7-nitro-2,1,3-benzoxadiazole-glucosylceramide	isoform EGCrP2, at pH 6.0 and 37°C	732178	
3.2.1.123	16.9	-	4-nitrophenyl-beta-D-glucoside	isoform EGCrP2, at pH 6.0 and 37°C	732178	
3.2.1.123	25.7	-	4-methylumbelliferyl beta-D-glucoside	isoform EGCrP2, at pH 6.0 and 37°C	732178	
3.2.1.123	45.7	-	beta-D-Gal-(1->3)-beta-D-GalNAc-(1->4)-(alpha-Neu5Ac-(2->3))-beta-D-Gal-(1->4)-beta-D-Glc-(1<->1')-ceramide	pH 6.0, 37°C	751102	
3.2.1.123	190	-	ganglioside Gb3Cer	isoform EHCase I, pH 5.5 and 37°C	732295	
3.2.1.123	320	-	ganglioside GM1a	isoform EHCase I, pH 5.5 and 37°C	732295	
3.2.1.123	504	-	resorufin	isoform EGCrP2, at pH 6.0 and 37°C	732178